Colangelo Dominick, President and CEO of Vericel Corporation (VCEL), has filed 58 Form 4 transactions across a single company, with a clear directional bias toward selling. Over the entire reporting period, his open-market sales totaled $11,784,961.27, while he recorded zero open-market purchases. The most recent cluster of activity, however, consists entirely of non-discretionary events: equity awards (code A) and shares withheld to cover tax obligations (code F) in February 2026, alongside option exercises (code M) at no cash value. These transactions carry no dollar value for the awards or exercises themselves, though the tax-withholding sales on February 18 and February 24, 2026, amounted to $211,628.37 and $336,106.16, respectively.
The discretionary selling pattern is concentrated in two prior windows. On March 12 and March 13, 2025, Colangelo executed open-market sales (code S) of VCEL worth $1,231,429.21 and $1,217,381.76, each paired with option exercises valued at roughly $51,850. A similar structure appeared in June 2024, with sales of $772,100 and $754,250 on June 12 and June 13, respectively, again matched by option exercises of $52,850 each. These paired transactions—exercise then immediate sale—are typical of a cashless exercise strategy, converting vested options into liquid shares rather than building a larger long-term position.
Notably, Colangelo has not reported a single open-market purchase (code P) in any filing, and his only other equity interest is a June 3, 2026, award in Trevi Therapeutics (TRVI), a separate company where he serves as President and CEO. That award carried a zero dollar value, indicating compensation rather than an investment decision. Across both tickers, the record shows a consistent pattern: compensation-driven accumulation and tax-related dispositions, with all discretionary trades in VCEL being sales. The absence of any buy-side conviction, combined with the recurring exercise-and-sell cadence, points to a portfolio manager monetizing equity compensation rather than signaling long-term accumulation.
AI-assisted summary